Entod Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.06 Cr
as on 23-10-2024
- Company Age 43 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.11 Cr
as on 23-10-2024
- Satisfied Charges ₹ 9.77 Cr
as on 23-10-2024
About Entod Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.06 Cr.
The company currently has active open charges totaling ₹13.11 Cr. The company has closed loans amounting to ₹9.77 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kishore Masurkar, Rita Masurkar, Nikhil Masurkar, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1981PLC025529
- Company No.
025529
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Oct 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Entod Pharmaceuticals Limited offer?
Entod Pharmaceuticals Limited offers a wide range of products and services, including Chrome Ore, Base Metal Ores, Manganese Ore, Vitamins & Supplements, Mineral Supplements, Health Conditions, Cold & Cough.
Who are the key members and board of directors at Entod Pharmaceuticals?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Masurkar  | Director | 01-Oct-2008 | Current |
| Kishore Masurkar | Whole-Time Director | 31-Oct-1981 | Current |
| Rita Masurkar | Director | 01-Oct-2011 | Current |
| Vinay Masurkar | Director | 25-Sep-2009 | Current |
| Dharmesh Kharwar | Additional Director | 03-Sep-2024 | Current |
| Vivek Shete | Director | 15-Jan-2022 | Current |
Financial Performance and Corporate Structure Insights of Entod Pharmaceuticals.
Entod Pharmaceuticals Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Entod Pharmaceuticals?
In 2023, Entod Pharmaceuticals had a promoter holding of 99.45% and a public holding of 0.55%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eyecirque Private LimitedActive 43 years 19 daysKishore Masurkar, Rita Masurkar and 1 more are mutual person
Entod Healthcare Private LimitedActive 19 years 11 monthsKishore Masurkar, Rita Masurkar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Mar 2021 | ₹1.10 M | Open |
Hdfc Bank Limited Creation Date: 13 Oct 2016 | ₹13.00 Cr | Open |
Hdfc Bank Limited Creation Date: 24 Jun 2021 | ₹6.00 M | Satisfied |
How Many Employees Work at Entod Pharmaceuticals?
Entod Pharmaceuticals has a workforce of 1092 employees as of Apr 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Entod Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Entod Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
